148 related articles for article (PubMed ID: 6432407)
1. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.
Garcia-Morteo O; Suarez-Almazor ME; Maldonado-Cocco JA; Cuttica R; Abate S
Clin Rheumatol; 1984 Jun; 3(2):223-7. PubMed ID: 6432407
[TBL] [Abstract][Full Text] [Related]
2. Early experiences with auranofin in juvenile rheumatoid arthritis.
Brewer EJ; Giannini EH; Person DA
Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
[TBL] [Abstract][Full Text] [Related]
3. Auranofin in the treatment of juvenile rheumatoid arthritis.
Giannini EH; Brewer EJ; Person DA
J Pediatr; 1983 Jan; 102(1):138-41. PubMed ID: 6401327
[TBL] [Abstract][Full Text] [Related]
4. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
Giannini EH; Brewer EJ; Person DA
Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
[TBL] [Abstract][Full Text] [Related]
5. Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.
Kvien TK; Høyeraal HM; Sandstad B; Kåss E
Clin Rheumatol; 1984 Dec; 3(4):551-2. PubMed ID: 6441669
[No Abstract] [Full Text] [Related]
6. Gold in rheumatoid arthritis therapy today. Paediatrics.
Svantesson H
Scand J Rheumatol Suppl; 1983; 51():125-6. PubMed ID: 6426047
[No Abstract] [Full Text] [Related]
7. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
Siegmeth W
Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
Rainer F; Ulreich A
Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
[No Abstract] [Full Text] [Related]
9. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
10. Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis.
Fantini F; Cottafava F; Martini A; Murelli M; Franchini E; D'Errico R; Panzarasa R
Int J Clin Pharmacol Res; 1986; 6(1):61-7. PubMed ID: 3082775
[TBL] [Abstract][Full Text] [Related]
11. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study.
van Riel PL; van de Putte LB; Gribnau FW; Macrae KD
Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414
[TBL] [Abstract][Full Text] [Related]
12. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
13. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
[TBL] [Abstract][Full Text] [Related]
14. An European open multicentre trial with auranofin in rheumatoid arthritis.
Raeman F; Hanssens F; Delattre M
Clin Rheumatol; 1984 Mar; 3 Suppl 1():33-8. PubMed ID: 6432411
[TBL] [Abstract][Full Text] [Related]
15. Auranofin versus placebo in the treatment of rheumatoid arthritis.
Wenger ME; Alexander S; Bland JH; Blechman WJ
Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter double-blind comparison of auranofin and Tauredon].
Kaik B; Bröll H
Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
[TBL] [Abstract][Full Text] [Related]
17. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
Horton RJ
Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
[TBL] [Abstract][Full Text] [Related]
19. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
Giannini EH; Person DA; Brewer EJ; Parks DB
J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
[TBL] [Abstract][Full Text] [Related]
20. Auranofin: a unique oral chrysotherapeutic agent.
Blodgett RC; Heuer MA; Pietrusko RG
Semin Arthritis Rheum; 1984 Feb; 13(3):255-73. PubMed ID: 6427927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
